RXO, Inc.
RXO · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,593 | $2,649 | $3,209 | $3,919 |
| - Cash | $0 | $18 | $16 | $35 |
| + Debt | $1 | $679 | $685 | $664 |
| Enterprise Value | $2,593 | $3,310 | $3,878 | $4,548 |
| Revenue | $1,421 | $1,419 | $1,433 | $1,667 |
| % Growth | 0.1% | -1% | -14% | – |
| Gross Profit | $236 | $254 | $232 | $260 |
| % Margin | 16.6% | 17.9% | 16.2% | 15.6% |
| EBITDA | $20 | $40 | $22 | $42 |
| % Margin | 1.4% | 2.8% | 1.5% | 2.5% |
| Net Income | -$14 | -$9 | -$31 | -$25 |
| % Margin | -1% | -0.6% | -2.2% | -1.5% |
| EPS Diluted | -0.08 | -0.053 | -0.18 | -0.12 |
| % Growth | -49.8% | 70.3% | -50% | – |
| Operating Cash Flow | $23 | $23 | -$2 | -$7 |
| Capital Expenditures | -$14 | -$14 | -$15 | -$12 |
| Free Cash Flow | $9 | $9 | -$17 | -$19 |